Aardvark Therapeutics, Inc. AARD
We take great care to ensure that the data presented and summarized in this overview for Aardvark Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in AARD
Top Purchases
Top Sells
About AARD
Insider Transactions at AARD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+28.46%
|
$20,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
2,667,299
+50.0%
|
-
|
|
Feb 14
2025
|
Jeffrey Chi |
BUY
Conversion of derivative security
|
Indirect |
133,364
+50.0%
|
-
|
|
Feb 14
2025
|
Vickers Venture Fund Vi Pte LTD |
BUY
Conversion of derivative security
|
Indirect |
2,050,902
+33.39%
|
-
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,542
+1.09%
|
$264,672
$16.0 P/Share
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
41,303
+2.72%
|
-
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.13%
|
$160,000
$16.0 P/Share
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
7,001
+7.26%
|
-
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
187,500
+15.95%
|
$3,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
800,189
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
7.16M
Shares
From
10
Insiders
| Conversion of derivative security | 5.7M shares |
|---|---|
| Open market or private purchase | 1.46M shares |
Sell / Disposition
0
Shares
From
0
Insiders